Evidence map›Paper›PMID 40720189›Full record

ArticleCritical care explorations2025

Comparative Evaluation of Lipopolysaccharide Administration Methods to Induce Acute Lung Injury in Murine Models: Efficacy, Consistency, and Technical Considerations.

Eva Kuhar, Duncan J Stewart, Doreen Engelberts, Forough Jahandideh, Matthew S Jeffers, Julie Khang, Haibo Zhang, Arnold S Kristof, Bernard Thébaud, Arul Vadivel and 2 more

Abstract readComparative Study
In one paragraph

Article in Critical care explorations, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Eva KuharAcute Care Researchl Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Duncan J StewartDepartment of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada.
Doreen EngelbertsAcute Care Researchl Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Forough JahandidehAcute Care Researchl Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Matthew S JeffersAcute Care Researchl Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Julie KhangKeenan Research Centre for Biomedical Science, St. Michael's Hospital, Unity Health Toronto, ON, Canada.
Haibo ZhangKeenan Research Centre for Biomedical Science, St. Michael's Hospital, Unity Health Toronto, ON, Canada.
Arnold S KristofMeakins-Christie Laboratories and Translational Research in Respiratory Diseases Program, Research Institute of the McGill University Health Centre, Faculty of Medicine, McGill University, Montreal, QC, Canada.
Bernard ThébaudRegenerative Medicine Program, The Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Arul VadivelRegenerative Medicine Program, The Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Dean A FergussonAcute Care Researchl Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Manoj M LaluAcute Care Researchl Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, Ottawa, ON, Canada.ORCID 0000-0002-0322-382

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextDirect preclinical lipopolysaccharide acute lung injury (ALI) models are commonly used to study acute respiratory distress syndrome. Differences in lipopolysaccharide delivery methods may impact lung injury severity and reproducibility. HYPOTHESIS: We hypothesized that the severity and variability of ALI outcomes in mice would differ depending on the technique of lipopolysaccharide administration. METHODS AND MODELS: Male and female C57BL/6 mice were administered lipopolysaccharide (2.25 mg/kg) via four methods: 1) intratracheal intubation; 2) intranasal; 3) surgical transtracheal by either needle puncture; or 4) by catheter. ALI severity and variability were assessed at 72 hours post-lipopolysaccharide via histological scoring and bronchoalveolar lavage fluid (BALF) analysis (total protein, cell counts, interleukin-6 [IL-6]). The relative distribution of Evans Blue dye was also assessed for each model (lungs vs. stomach).

resultsDistinct lung injury patterns were observed between the four methods. The transtracheal with catheter method demonstrated significantly greater lung injury scores than the intratracheal intubation and intranasal techniques. Both transtracheal methods produced greater alveolar neutrophil counts, increased proteinaceous debris, fewer hyaline membranes, and lower variability than non-surgical techniques. The transtracheal with catheter method produced higher BALF total cell counts and IL-6 levels than intratracheal intubation. Transtracheal methods also resulted in more localized Evans Blue dye distribution in the lungs. Male mice exhibited more severe lung injury scores and higher BALF protein concentrations than females. INTERPRETATION AND

conclusionsThis study demonstrates that the choice of technique to administer lipopolysaccharide impacts injury severity, phenotype, and variability. The surgical transtracheal with catheter technique produced the most robust and least variable ALI phenotype; however, this technique is associated with increased procedural complexity. Our results will allow researchers to tailor their model choice to align with their specific study objectives.

Indexed as

Acute Lung InjuryLipopolysaccharidesAdministration, IntranasalAnimalsBronchoalveolar Lavage FluidDisease Models, AnimalFemaleIntubation, IntratrachealMaleMiceMice, Inbred C57BLReproducibility of ResultsLipopolysaccharidesacute lung injuryacute respiratory distress syndromebiological sexdisease modelslipopolysaccharidesex factors

Identifiers

PMID40720189
PMCPMC12306704

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.